Sex determines which section of the SLC6A4 gene is linked to obsessive-compulsive symptoms in normal Chinese college students

Journal of Psychiatric Research

Volumn 46, Issue 9, 2012, Pages 1153-1160

  Lei, Xuemei ^a,b   Chen, Chuansheng ^b   He, Qinghua ^d   Chen, Chunhui ^a   Moyzis, Robert K ^c   Xue, Gui ^a,d   Chen, Xiongying ^a   Cao, Zhongyu ^a   Li, Jin ^a   Li, He ^a   Zhu, Bi ^a   Chun Hsu, Anna Shan ^b   Li, Sufang ^a   Li, Jun ^a   Dong, Qi ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

5 HTTLPR; Gender; Haplotype; Obsessive compulsive disorder; Obsessive compulsive symptoms; SLC6A4; STin2

Indexed keywords

SEROTONIN TRANSPORTER;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CHINESE; COLLEGE STUDENT; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM REPEAT;

ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; OBSESSIVE-COMPULSIVE DISORDER; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX CHARACTERISTICS; STUDENTS; UNIVERSITIES; YOUNG ADULT;

EID: 84864384642     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.05.002     Document Type: Article

References (79)

1. Abed R.T., de Pauw K.W. An evolutionary hypothesis for obsessive compulsive disorder: a psychological immune system?. Behavioural Neurology 1998, 11:245-250.
2. APA Practice parameters for the treatment of patients with obsessive-compulsive disorder 2007, American Psychiatric Association, Arlington, VA.
3. Apter A., Fallon T.J., King R.A., Ratzoni G., Zohar A.H., Binder M., et al. Obsessive-compulsive characteristics: from symptoms to syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 1996, 35:907-912.
4. Baca-Garcia E., Vaquero-Lorenzo C., Diaz-Hernandez M., Rodriguez-Salgado B., Dolengevich-Segal H., Arrojo-Romero M., et al. Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007, 31:416-420.
5. Bamber D., Tamplin A., Park R.J., Kyte Z.A., Goodyer I.M. Development of a short Leyton obsessional inventory for children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41:1246-1252.
6. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
7. Baune B.T., Hohoff C., Mortensen L.S., Deckert J., Arolt V., Domschke K. Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect?. Depression and Anxiety 2008, 25:920-925.
8. Beam M.R., Gil-Rivas V., Greenberger E., Chen C.S. Adolescent problem behavior and depressed mood: risk and protection within and across social contexts. Journal of Youth and Adolescence 2002, 31:343-357.
9. Beck A.T. Beck anxiety inventory manual 1990, Psychological Corporation, San Antonio, TX.
10. Beck A.T., Steer R.A., Ball R., Ranieri W. Comparison of Beck depression inventories -IA and -II in psychiatric outpatients. Journal of Personality Assessment 1996, 67:588-597.
11. Bengel D., Greenberg B.D., Cora-Locatelli G., Altemus M., Heils A., Li Q., et al. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Molecular Psychiatry 1999, 4:463-466.
12. Berg C.Z., Whitaker A., Davies M., Flament M.F., Rapoport J.L. The survey form of the Leyton obsessional inventory-child version: norms from an epidemiological study. Journal of the American Academy of Child and Adolescent Psychiatry 1988, 27:759-763.
13. Bloch M.H., Landeros-Weisenberger A., Rosario M.C., Pittenger C., Leckman J.F. Meta-analysis of the symptom structure of obsessive-compulsive disorder. The American Journal of Psychiatry 2008, 165:1532-1542.
14. Bloch M.H., Landeros-Weisenberger A., Sen S., Dombrowski P., Kelmendi B., Coric V., et al. Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B:850-858.
15. Blom R.M., Samuels J.F., Riddle M.A., Joseph Bienvenu O., Grados M.A., Reti I.M., et al. Association between a serotonin transporter promoter polymorphism (5HTTLPR) and personality disorder traits in a community sample. Journal of Psychiatric Research 2011, 45:1153-1159.
16. Bocklandt S., Vilain E. Sex differences in brain and behavior: hormones versus genes. Advances in Genetics 2007, 59:245-266.
17. Brummett B.H., Boyle S.H., Siegler I.C., Kuhn C.M., Ashley-Koch A., Jonassaint C.R., et al. Effects of environmental stress and gender on associations among symptoms of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR). Behavior Genetics 2008, 38:34-43.
18. Brynska A., Wolanczyk T. Epidemiology and phenomenology of obsessive-compulsive disorder in non-referred young adolescents: a Polish perspective. European Child & Adolescent Psychiatry 2005, 14:319-327.
19. Buckholtz J.W., Callicott J.H., Kolachana B., Hariri A.R., Goldberg T.E., Genderson M., et al. Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Molecular Psychiatry 2008, 13:313-324.
20. Buckholtz J.W., Meyer-Lindenberg A. MAOA and the neurogenetic architecture of human aggression. Trends in Neurosciences 2008, 31:120-129.
21. Cahill L. Why sex matters for neuroscience. Nature Reviews. Neuroscience 2006, 7:477-484.
22. Camarena B., Rinetti G., Cruz C., Hernandez S., de la Fuente J.R., Nicolini H. Association study of the serotonin transporter gene polymorphism in obsessive-compulsive disorder. The International Journal of Neuropsychopharmacology 2001, 4:269-272.
23. Carter A.S., Pollock R.A., Suvak M.K., Pauls D.L. Anxiety and major depression comorbidity in a family study of obsessive-compulsive disorder. Depression and Anxiety 2004, 20:165-174.
24. Chabane N., Millet B., Delorme R., Lichtermann D., Mathieu F., Laplanche J.L., et al. Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive-compulsive disorder by case control and family association study in humans. Neuroscience Letters 2004, 363:154-156.
25. Chen C., Moyzis R., Dong Q., He Q., Zhu B., Li J., et al. Sex modulates the associations between the COMT gene and personality traits. Neuropsychopharmacology 2011, 36:1593-1598.
26. Chiao J.Y., Blizinsky K.D. Culture-gene coevolution of individualism-collectivism and the serotonin transporter gene. Proceedings of the Royal Society of London. Series B 2010, 277:529-537.
27. Dickel D.E., Veenstra-VanderWeele J., Bivens N.C., Wu X.L., Fischer D.J., Van Etten-Lee M., et al. Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder. Biological Psychiatry 2007, 61:322-329.
28. Fiskerstrand C.E., Lovejoy E.A., Quinn J.P. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Letters 1999, 458:171-174.
29. Gelernter J., Kranzler H., Cubells J.F. Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Human Genetics 1997, 101:243-246.
30. Geller D.A., Biederman J., Stewart S.E., Mullin B., Martin A., Spencer T., et al. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. The American Journal of Psychiatry 2003, 160:1919-1928.
31. Goddard A.W., Shekhar A., Whiteman A.F., McDougle C.J. Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discovery Today 2008, 13:325-332.
32. Greenberg B.D., Tolliver T.J., Huang S.J., Li Q., Bengel D., Murphy D.L. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. American Journal of Medical Genetics 1999, 88:83-87.
33. Harrison P.J., Tunbridge E.M. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 2008, 33:3037-3045.
34. Hasselbalch S.G., Hansen E.S., Jakobsen T.B., Pinborg L.H., Lonborg J.H., Bolwig T.G. Reduced midbrain-pons serotonin transporter binding in patients with obsessive-compulsive disorder. Acta Psychiatrica Scandinavica 2007, 115:388-394.
35. He Q., Xue G., Chen C., Lu Z., Dong Q., Lei X., et al. Serotonin transporter gene-linked polymorphic region (5-HTTLPR) influences decision making under ambiguity and risk in a large Chinese sample. Neuropharmacology 2010, 59:518-526.
36. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., et al. Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry 1996, 66:2621-2624.
37. Henry P.J. College sophomores in the laboratory redux: influences of a narrow data base on social psychology's view of the nature of prejudice. Psychological Inquiry 2008, 19:49-71.
38. Hesse S., Stengler K., Regenthal R., Patt M., Becker G.A., Franke A., et al. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. The International Journal of Neuropsychopharmacology 2011, 14:606-617.
39. Hranilovic D., Stefulj J., Schwab S., Borrmann-Hassenbach M., Albus M., Jernej B., et al. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biological Psychiatry 2004, 55:1090-1094.
40. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. American Journal of Human Genetics 2006, 78:815-826.
41. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62:593-602.
42. Kessler R.C., Demler O., Frank R.G., Olfson M., Pincus H.A., Walters E.E., et al. Prevalence and treatment of mental disorders, 1990 to 2003. The New England Journal of Medicine 2005, 352:2515-2523.
43. Kim S.J., Lee H.S., Kim C.H. Obsessive-compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism. Neuropsychobiology 2005, 52:176-182.
44. Kim Y.D., Lee J.Y., Oh K.M., Araki M., Araki K., Yamamura K., et al. NSrp70 is a novel nuclear speckle-related protein that modulates alternative pre-mRNA splicing in vivo. Nucleic Acids Research 2011, 39:4300-4314.
45. Lensi P., Cassano G.B., Correddu G., Ravagli S., Kunovac J.L., Akiskal H.S. Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences. The British Journal of Psychiatry 1996, 169:101-107.
46. Lesch K.P., Gutknecht L. Pharmacogenetics of the serotonin transporter. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2005, 29:1062-1073.
47. Li J., Wang Y., Zhou R., Zhang H., Yang L., Wang B., et al. Association between polymorphisms in serotonin transporter gene and attention deficit hyperactivity disorder in Chinese Han subjects. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2007, 144B:14-19.
48. Li Y., Marques L., Hinton D.E., Wang Y., Xiao Z.P. Symptom dimensions in Chinese patients with obsessive-compulsive disorder. CNS Neuroscience and Therapeutics 2009, 15:276-282.
49. Lin P.Y. Meta-analysis of the association of serotonin transporter gene polymorphism with obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007, 31:683-689.
50. Maggini C., Ampollini P., Gariboldi S., Cella P.L., Peqlizza L., Marchesi C. The Parma high school epidemiological survey: obsessive-compulsive symptoms. Acta Psychiatrica Scandinavica 2001, 103:441-446.
51. Mather A., Cartwright-Hatton S. Cognitive predictors of obsessive-compulsive symptoms in adolescence: a preliminary investigation. Journal of Clinical Child & Adolescent Psychology 2004, 33:743-749.
52. Mathews C.A., Jang K.L., Hami S., Stein M.B. The structure of obsessionality among young adults. Depression and Anxiety 2004, 20:77-85.
53. McDougle C.J., Epperson C.N., Price L.H., Gelernter J. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Molecular Psychiatry 1998, 3:270-273.
54. Middeldorp C.M., de Geus E.J., Beem A.L., Lakenberg N., Hottenga J.J., et al. Family based association analyses between the serotonin transporter gene polymorphism (5-HTTLPR) and neuroticism, anxiety and depression. Behavior Genetics 2007, 37:294-301.
55. Mizuno T., Aoki M., Shimada Y., Inoue M., Nakaya K., Takahashi T., et al. Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety. Journal of Psychosomatic Research 2006, 60:91-97.
56. Moore J., Smith G.W., Shevlin M., O'Neill F.A. Alternative factor models and heritability of the short Leyton obsessional inventory-children's version. Journal of Abnormal Child Psychology 2010, 38:921-934.
57. Nackley A.G., Shabalina S.A., Tchivileva I.E., Satterfield K., Korchynskyi O., Makarov S.S., et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006, 314:1930-1933.
58. Ngun T.C., Ghahramani N., Sanchez F.J., Bocklandt S., Vilain E. The genetics of sex differences in brain and behavior. Frontiers in Neuroendocrinology 2011, 32:227-246.
59. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. American Journal of Human Genetics 2004, 74:765-769.
60. Ogilvie A.D., Battersby S., Bubb V.J., Fink G., Harmar A.J., Goodwim G.M., et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 1996, 347:731-733.
61. Ohara K., Suzuki Y., Ochiai M., Tsukamoto T., Tani K. A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1999, 23:55-65.
62. Perez M., Brown J.S., Vrshek-Schallhorn S., Johnson F., Joiner T.E. Differentiation of obsessive-compulsive-, panic-, obsessive-compulsive personality-, and non-disordered individuals by variation in the promoter region of the serotonin transporter gene. Journal of Anxiety Disorders 2006, 20:794-806.
63. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A.R., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 2007, 81:559-575.
64. Quarantini L.C., Torres A.R., Sampaio A.S., Fossaluza V., Mathis M.A., do Rosario M.C., et al. Comorbid major depression in obsessive-compulsive disorder patients. Comprehensive Psychiatry 2011, 52:386-393.
65. Richter M.A., Cox B.J., Direnfeld D.M. A comparison of three assessment instruments for obsessive-compulsive symptoms. Journal of Behavior Therapy and Experimental Psychiatry 1994, 25:143-147.
66. Roussos A., Francis K., Koumoula A., Richardson C., Kabakos C., Kiriakidou T., et al. The Leyton obsessional inventory - child version in Greek adolescents: standardization in a national school-based survey and two-year follow-up. European Child & Adolescent Psychiatry 2003, 12:58-66.
67. Sanchez F.J., Vilain E. Genes and brain sex differences. Progress in Brain Research 2010, 186:65-76.
68. Sears D.O. College sophomores in the laboratory: influences of a narrow data base on social psychology's view of human nature. Journal of Personality and Social Psychology 1986, 51(3):515-530.
69. Smits K.M., Smits L.J., Peeters F.P., Schouten J.S., Janssen R.G., Smeets H.J., et al. The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients. Psychiatric Genetics 2008, 18:184-190.
70. Smits K.M., Smits L.J., Schouten J.S., Stelma F.F., Nelemans P., Prins M.H. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Molecular Psychiatry 2004, 9:433-441.
71. van Grootheest D.S., Cath D.C., Beekman A.T., Boomsma D.I. Twin studies on obsessive-compulsive disorder: a review. Twin Research and Human Genetics 2005, 8:450-458.
72. Voyiaziakis E., Evgrafov O., Li D., Yoon H.J., Tabares P., Samuels J., et al. Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study. Molecular Psychiatry 2011, 16:108-120.
73. Walitza S., Wendland J.R., Gruenblatt E., Warnke A., Sontag T.A., Tucha O., et al. Genetics of early-onset obsessive-compulsive disorder. European Child & Adolescent Psychiatry 2010, 19:227-235.
74. Wang E.T., Kodama G., Baldi P., Moyzis R.K. Global landscape of recent inferred Darwinian selection for Homo sapiens. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:135-140.
75. Wendland J.R., Moya P.R., Kruse M.R., Ren-Patterson R.F., Jensen C.L., Timpano K.R., et al. A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder. Human Molecular Genetics 2008, 17:717-723.
76. Wills T.A., Vaccaro D., Mcnamara G. The role of life events, family support, and competence in adolescent substance use - a test of vulnerability and protective factors. American Journal of Community Psychology 1992, 20:349-374.
77. Zhang J.L., Yang J.F., Chan P. No association between polymorphism of serotonin transporter gene and depression in Parkinson's disease in Chinese. Neuroscience Letters 2009, 455:155-158.
78. Zhang Y., Bertolino A., Fazio L., Blasi G., Rampino A., Romano R., et al. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:20552-20557.
79. Zhong S., Israel S., Xue H., Sham P.C., Ebstein R.P., Chew S.H. A neurochemical approach to valuation sensitivity over gains and losses. Proceedings of the Royal Society of London. Series B 2009, 276:4181-4188.